Aperio Group LLC reduced its stake in Vitamin Shoppe, Inc (NYSE:VSI) by 33.4% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 22,993 shares of the specialty retailer’s stock after selling 11,533 shares during the quarter. Aperio Group LLC owned 0.10% of Vitamin Shoppe worth $123,000 at the end of the most recent reporting period.

Several other hedge funds also recently modified their holdings of VSI. Vanguard Group Inc. lifted its holdings in Vitamin Shoppe by 14.8% during the 1st quarter. Vanguard Group Inc. now owns 2,186,549 shares of the specialty retailer’s stock worth $44,059,000 after buying an additional 282,598 shares in the last quarter. FMR LLC increased its position in shares of Vitamin Shoppe by 32.4% in the 2nd quarter. FMR LLC now owns 1,254,690 shares of the specialty retailer’s stock valued at $14,617,000 after purchasing an additional 307,050 shares during the last quarter. State Street Corp increased its position in shares of Vitamin Shoppe by 9.2% in the 1st quarter. State Street Corp now owns 721,483 shares of the specialty retailer’s stock valued at $14,535,000 after purchasing an additional 60,575 shares during the last quarter. Schwab Charles Investment Management Inc. increased its position in shares of Vitamin Shoppe by 34.6% in the 2nd quarter. Schwab Charles Investment Management Inc. now owns 262,123 shares of the specialty retailer’s stock valued at $3,054,000 after purchasing an additional 67,362 shares during the last quarter. Finally, Canada Pension Plan Investment Board increased its position in shares of Vitamin Shoppe by 80.6% in the 2nd quarter. Canada Pension Plan Investment Board now owns 236,900 shares of the specialty retailer’s stock valued at $2,760,000 after purchasing an additional 105,700 shares during the last quarter. Hedge funds and other institutional investors own 88.51% of the company’s stock.

Vitamin Shoppe, Inc (NYSE:VSI) remained flat at $$4.10 during mid-day trading on Wednesday. The company’s stock had a trading volume of 735,400 shares, compared to its average volume of 515,904. Vitamin Shoppe, Inc has a 1 year low of $2.95 and a 1 year high of $26.25. The company has a market cap of $91.11, a price-to-earnings ratio of 4.09 and a beta of 0.74. The company has a current ratio of 2.07, a quick ratio of 0.32 and a debt-to-equity ratio of 0.59.

Vitamin Shoppe (NYSE:VSI) last released its earnings results on Wednesday, November 8th. The specialty retailer reported ($0.03) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.17 by ($0.20). Vitamin Shoppe had a positive return on equity of 6.17% and a negative net margin of 20.27%. The firm had revenue of $288.20 million during the quarter, compared to analyst estimates of $297.61 million. During the same quarter last year, the business posted $0.50 EPS. The firm’s revenue was down 8.5% on a year-over-year basis. sell-side analysts predict that Vitamin Shoppe, Inc will post 0.44 earnings per share for the current year.

A number of research analysts recently commented on VSI shares. Goldman Sachs Group reaffirmed a “sell” rating and issued a $6.00 target price (down from $13.00) on shares of Vitamin Shoppe in a research report on Thursday, August 10th. Deutsche Bank reaffirmed a “hold” rating and issued a $7.00 target price (down from $14.00) on shares of Vitamin Shoppe in a research report on Thursday, August 10th. Barclays dropped their target price on shares of Vitamin Shoppe from $13.00 to $6.00 and set an “equal weight” rating on the stock in a research report on Thursday, August 10th. TheStreet downgraded shares of Vitamin Shoppe from a “c-” rating to a “d” rating in a research report on Wednesday, August 9th. Finally, Morgan Stanley set a $8.00 target price on shares of Vitamin Shoppe and gave the company a “hold” rating in a research report on Thursday, August 10th. Four equities research analysts have rated the stock with a sell rating, four have given a hold rating and one has assigned a buy rating to the company. The company presently has a consensus rating of “Hold” and an average target price of $5.00.

WARNING: “Vitamin Shoppe, Inc (VSI) Holdings Trimmed by Aperio Group LLC” was first published by Daily Political and is the property of of Daily Political. If you are accessing this report on another website, it was illegally copied and republished in violation of US & international copyright & trademark legislation. The correct version of this report can be accessed at https://www.dailypolitical.com/2017/11/29/vitamin-shoppe-inc-vsi-holdings-trimmed-by-aperio-group-llc.html.

Vitamin Shoppe Profile

Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, direct and manufacturing. The retail segment includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats.

Institutional Ownership by Quarter for Vitamin Shoppe (NYSE:VSI)

Receive News & Ratings for Vitamin Shoppe Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe Inc and related companies with MarketBeat.com's FREE daily email newsletter.